Navigation Links
FDA Panel Weighs OK of 'Female Viagra'
Date:6/18/2010

Recent research has shown increase in sexual satisfaction, if not libido

FRIDAY, June 18 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Friday was considering whether to approve a drug dubbed the "female Viagra" for premenopausal women with a diminished sex drive.

Called flibanserin, the drug is related to the antidepressant family and affects serotonin and other chemicals in the brain. Drug maker Boehringer Ingelheim has been seeking FDA approval of the drug.

While the agency isn't compelled to follow the recommendations of its advisory panels, it typically does so.

Earlier this week, the FDA released a review of two studies that found the drug didn't have much impact on a woman's libido but did seem to slightly boost sexual satisfaction, according to published reports.

Side effects seen with use of the drug included depression, fainting and dizziness, the FDA said.

The drug, with the proposed brand name Girosa, is designed to be taken in 100-milligram pills once a day at bedtime, according to the FDA.

Since the extraordinary success of Viagra for men, which hit the market a decade ago, pharmaceutical companies have repeatedly tried to find a comparable drug treatment for women. But none of those treatments has resulted in a significant benefit.

More information

To learn more about women's sexual health, visit the International Society for the Study of Women's Sexual Health.



-- HealthDay staff



SOURCES: U.S. Food and Drug Administration Web site


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. NFL Brain Injury Panel Raises Awareness of Potential Long-Term Consequences from Traumatic Brain Injuries
2. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
3. Federal Panel Urges Obesity Screening for Kids Ages 6 and Up
4. Scientific panel evaluates soy infant formula safety
5. Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned
6. PolitiFact Names 'Death Panels' Claim the Lie of the Year
7. Expert Panel Reaches Consensus on Our Ability to Improve Cognitive Health
8. Panel Intelligence Returns to MedPanel Name
9. Panel asks dairy avoiders: Are you getting enough?
10. Avoiding Dairy Due to Lactose Intolerance is Unnecessary in Most Cases and May Pose Diet and Health Risks, Concludes National Institutes of Health Consensus Development Conference Panel
11. All Global Launches Physician Panels in Russia and Poland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: